Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced Chris Mansi, M.D., CEO and Co-founder, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 4, 2024 at 1:05 p.m. ET in New York, NY.

Dr. Mansi will share how Viz.ai is transforming last mile delivery of AI-powered workflows in healthcare with a broadly deployed AI safety net to ensure no patient is missed, helping providers and life sciences to bridge care gaps and increase patient access to life-saving treatments. With the growing need to reinvent the pharmaceutical commercial model as the Inflation Reduction Act puts pressure on drug prices, Viz.ai’s AI-Powered Care Accelerator is uniquely positioned to guide more patients to the right diagnosis, specialist, and treatment faster.

About Viz.ai

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,600+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai One™ is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240826984975/en/